NASDAQ: MRNAModerna Inc Stock Ownership
Insider buying vs selling
Have Moderna Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen Hoge | President | 2021-06-14 | 5,000 | $10.90 | $54.50kBuy |
| Stephen Hoge | President | 2021-06-14 | 10,000 | $0.99 | $9.90kBuy |
| Stephen Hoge | President | 2021-06-14 | 5,000 | $10.90 | $54.50kBuy |
| Stephen Hoge | President | 2021-06-14 | 20,000 | $213.32 | $4.27MSell |
| Juan Andres | Chief Technical Operations and Quality Officer | 2021-06-14 | 5,000 | $213.32 | $1.07MSell |
| Juan Andres | Chief Technical Operations and Quality Officer | 2021-06-14 | 5,000 | $12.21 | $61.05kBuy |
| Stephane Bancel | Chief Executive Officer | 2021-06-10 | 10,000 | $216.70 | $2.17MSell |
| Stephane Bancel | Chief Executive Officer | 2021-06-09 | 9,000 | $212.30 | $1.91MSell |
| Juan Andres | Chief Technical Operations and Quality Officer | 2021-06-09 | 5,000 | $12.21 | $61.05kBuy |
| Tal Zvi Zaks | Chief Medical Officer | 2021-06-09 | 5,000 | $212.30 | $1.06MSell |
MRNA insiders have sold more MRNA shares than they have bought in the last year
Ownership
MRNA Shareholders
What type of owners hold Moderna Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Noubar Afeyan | 20.30% | 81,490,098 | $16.12B | Insider |
| Baillie Gifford Co | 11.29% | 45,337,764 | $8.97B | Institution |
| Blackrock Inc | 5.18% | 20,803,397 | $4.12B | Institution |
| Flagship Pioneering Inc | 5.13% | 20,581,016 | $4.07B | Institution |
| Vanguard Group Inc | 4.71% | 18,919,030 | $3.74B | Institution |
| Stephane Bancel | 3.82% | 15,319,240 | $3.03B | Insider |
| Robert Langer | 2.87% | 11,509,357 | $2.28B | Insider |
| Morgan Stanley | 2.05% | 8,222,788 | $1.63B | Institution |
| Theleme Partners Llp | 1.57% | 6,302,056 | $1.25B | Institution |
| State Street Corp | 1.50% | 6,008,874 | $1.19B | Institution |
Moderna Stock Ownership FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.